Clinical Trial

Online Referral and Intervention to Prevent Adolescent and Young Adult Suicide

Study acronym: ORIAS
Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated June 27, 2025 (before its estimated July 13, 2026 completion). Its status may not reflect the trial's current state.
Summary
ORIAS is a randomized controlled trial designed to study the efficacy of the ELIOS system in reducing suicidality in the AYA, reinforcing their motivation to seek help and making them access to care. As ELIOS would be the first suicide prevention system worldwide entirely tailored to the AYA contemporaneous modes of interaction on social media, ORIAS was designed to address the challenge of deciding whether this innovation is worth adding to the current national and international prevention arsenal. While randomized control trials are crucially lacking in the field of suicide prevention, especially on the Internet, the high-level evidence that ORIAS is expected to bring could have a decisive influence on how the French prevention strategies will seize the social media.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2020-11-23; most recent amendment 2025-06-23.
Status change: Not Yet Recruiting → Recruiting 2025-06-23
Trial Details
NCT Number NCT04642157
Lead Sponsor University Hospital, Lille
Collaborators: Ministry of Health, France
Conditions Suicide
Enrollment 396 participants
Start Date 2022-10-13
Primary Completion 2026-07-13 (estimated)
Study Completion 2026-07-13 (estimated)
Updated on ClinicalTrials.gov 2025-06-27